Here are five key points:
1. The Intellis platform is designed for chronic intractable pain management.
2. Medtronic designed the platform to enhance existing spinal cord stimulation systems, by improving elements such as battery power.
3. The platform is able to power the Evolve workflow, which is intended to standardize guidance as well as balance dose therapy settings.
4. Managed on the Samsung Galaxy Tab S2 tablet, the Intellis platform records and tracks patient activity at all times.
5. Durham, N.C.-based Duke University Medical Center surgeons were among the first to implant a U.S. patient with the Intellis device.
More articles on devices:
TransEnterix submits additional information for surgical robotic system FDA clearance: 5 insights
Dr. Asif Ilyas completes 1st surgery using Globus Medical’s trauma fixation system: 5 takeaways
NuVasive, DePuy Synthes, Zimmer Biomet & more: 10 device company notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
